by Bovine mastitis is an inflammatory condition of the mammary gland of dairy cows. It is usually caused by bacterial infections, mainly streptococci, staphylcocci and coliforms that enter the udder through the teat canal. Pharmaceutical products such as antibiotics, painkillers, and anti-inflammatory drugs are effective in treating and preventing mastitis.
The global Bovine Mastitis Market is estimated to be valued at US$ 1497.52 Mn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trend in the bovine mastitis market is the development of teat sealants. Teat sealants act as a physical barrier at the end of the teat canal and help prevent new intramammary infection post dipping. They protect the udder from bacteria for 72 hours or more, reducing the risk of new infection. These products have gained popularity among dairy farmers as they provide reliable protection to dairy cows from mastitis.
SWOT Analysis
Strength: The bovine mastitis market has strong potential for growth due to increasing prevalence of mastitis disease affecting dairy cows globally. Early detection and prevention of bovine mastitis helps improve milk quality and productivity.
Weakness: High cost of veterinary treatments and vaccines for bovine mastitis poses major challenge in developing economies. Lack of proper farm management practices and infrastructure in some regions negatively impacts the bovine mastitis market.
Opportunity: Rising animal healthcare expenditure and growing focus on quality milk production presents lucrative opportunities for mastitis treatment and diagnostics market players. Development of advanced technologies for rapid diagnostics is another growth opportunity area.
Threats: Stringent regulations pertaining to antimicrobial usage in livestock may constrain market revenues. Threat of substitutes from alternative therapies also impact the bovine mastitis market.
Key Takeaways
The Global Bovine Mastitis Market Size is expected to reach US$ 1497.52 Million by 2023, expanding at a CAGR of 5.2% during 2023-2030. Increasing dairy cows population and growing consumption of dairy products globally is a major factor driving the bovine mastitis market growth.
Regional analysis: North America dominates the global bovine mastitis market with highest growth rate due to strong dairy farming industry and growing consumption of dairy products in the region. Asia Pacific is expected to be the fastest growing market owing to rising livestock population, increasing meat consumption in countries such as China and India.
Key players operating in the bovine mastitis market includes Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd. Major players focus on development and commercialization of novel vaccines as well as delivery devices which present minimum safety concerns to animals.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
